Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00244686
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2020-11-25
First Post:
2005-10-25
Brief Title:
This Record Contains Information About the Mepolizumab Compassionate Use CU Product Activities 104317 CU and Long-Term Access Study of Mepolizumab in HES 201956A Long-term Access Programme for Subjects With Severe Asthma 112562 Expanded Access for Patients With Hypereosinophilic
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-10-25
First Submit QC Date:
October 26 2005
Study First Post Date:
2005-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-23
Last Update Post Date:
2020-11-25
Last Update Post Date Type:
ACTUAL